High Flavonols Cocoa Intake for the Improvement of Body Fat Composition in Athletes
NCT ID: NCT04028128
Last Updated: 2019-09-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
40 participants
INTERVENTIONAL
2018-01-01
2019-04-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Cocoa Products on Cardiovascular Disease Risk Factors
NCT00511420
Effects of Acute Intake of Flavanols on Cerebral Oxygenation and Cognition in Young Male Adults
NCT04374409
Cocoa Intake for Health Promotion in Athletes
NCT03897114
Protective Effects of Cocoa Ingestion Over Healthy Males Plasma Lipids Subjected to Peroxidative Conditions
NCT01347450
Cocoa Flavanols and Exercise Capacity
NCT01259739
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
A randomized, blinded, parallel placebo controlled intervention study was carried out in endurance athletes . The number of male athletes enrolled in the study was 40, with ages between 18 and 50 years and an aerobic power consumption of oxygen greater than or equal to 55 mL / kg / min). The intervention was carried out for 10 weeks. Cocoa or placebo (maltodextrin) were supplied in sachets of a single daily dose. Cocoa provided 425 mg of flavanols/ day.
Athlete's body composition was evaluated by dual-energy X-ray absorptiometry (DEXA). Exercise performance was evaluated with a treadmill test protocol determining the maximum aerobic capacity and also by determining the time necessary to run a kilometer at maximum speed.
Adipokines (follistatin, myostatin and leptin) in plasma and serum samples were determined by ELISA.
Diet was determined by three 24h-recall questionnaries and a Food Frecuency questionnaire.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cocoa group
The cocoa was provided in 5 g sachets. The intervention last 10 weeks. Cocoa was provided in a single daily dose of 5 g, which provided 425 mg of flavonoids
Cocoa group
Athletes performed a training program and consumed 5 g of cocoa (425 mg of flavonoids) mixed with semi-skimmed fat milk, daily for 10 weeks.
Placebo group
Maltodextrin (5 g) was supplied as placebo in sachets identical to those provided for cocoa.
Placebo group
The athletes performed the same training program of the cocoa group and they took for 10 weeks 5 g of maltodextrin mixed with semi-skimmed fat milk.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cocoa group
Athletes performed a training program and consumed 5 g of cocoa (425 mg of flavonoids) mixed with semi-skimmed fat milk, daily for 10 weeks.
Placebo group
The athletes performed the same training program of the cocoa group and they took for 10 weeks 5 g of maltodextrin mixed with semi-skimmed fat milk.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age between 18 and 50 years
* Aerobic power of oxygen consumption greater than or equal to 55 mL / kg / min
Exclusion Criteria
* Intake any type of nutritional or ergogenic supplements.
* Vegetarian or vegan diet
* Smoke.
* Any diagnosed disease at the time of inclusion or during the study
18 Years
50 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ministerio de Economía y Competitividad, Spain
OTHER_GOV
Universidad Europea de Madrid
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mar Larrosa
Tenure Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
María del Mar Larrosa Pérez, PhD
Role: PRINCIPAL_INVESTIGATOR
Universidad Europea de Madrid
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Jose Ángel García Merino
Villaviciosa de Odón, Madrid, Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AGL2016-77288-R-2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.